The tide appears to be turning for Yangzijiang Shipbuilding, after its MSCI rebalancing in early November set it by 5 - 39% behind his peers, observes DBS analyst Ho Pei Hwa.

Following this, the counter has been left out in the recent equity rally and rotational interests into cyclicals to position for an economic recovery that came after news on the progress of the Covid-19 vaccine development.

Instead, Yangzijiang’s share price dipped by 1%. This was an underperformance of 17% against the straits times index and up to 39% vis-à-vis regional shipyards.


To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook